top of page

OUR COMMITTEES

About_Committee_COL.jpg

Each committee will play an essential part in the selection of speakers for the annual congress.
They will also have a direct implication on the abstract selection.

The chairs are nominated by the ESGCT board and it is up to the chairs to decide who should sit on their committee, one of the committee members should be from the US or non-European continents, and another one from the co-organising National Society, this person would change every year. 

AAV & non integrative vectors

Accessibility of gene therapy

Bleeding
disorders

Cardiovascular & muscular diseases

CNS & sensory diseases

Disease models, IPS cells & organoids

Gene editing

Hematopoietic diseases & PID

Immune responses to gene therapy

Immunotherapy & CART cells

Infectious diseases & vaccines

Lentiviral & integrative vectors

Manufacturing

Metabolic
diseases

Non viral vectors | 
Nano-technology | 
RNA therapeutics 

Oncolytic & cancer gene therapy

Skin, pulmonary & skeletal diseases

Regulatory

bottom of page